|
1
|
WHO. Global tuberculosis report 2012.
Geneva: World Health Organization. URL: http://www.who.int/tb/publications/global_report/en/index.html.
2012
|
|
2
|
Lawn SD and Zumla AI: Tuberculosis.
Lancet. 378:57–72. 2011. View Article : Google Scholar
|
|
3
|
Boehme CC, Nabeta P, Hillemann D, et al:
Rapid molecular detection of tuberculosis and rifampin resistance.
N Engl J Med. 363:1005–1015. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dosanjh DP, Hinks TS, Innes JA, et al:
Improved diagnostic evaluation of suspected tuberculosis. Ann
Intern Med. 148:325–336. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tu HA, Vu HD, Rozenbaum MH, Woerdenbag HJ
and Postma MJ: A review of the literature on the economics of
vaccination against TB. Expert Rev Vaccines. 11:303–317. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lagranderie MR, Balazuc AM, Deriaud E,
Leclerc CD and Gheorghiu M: Comparison of immune responses of mice
immunized with five different Mycobacterium bovis BCG
vaccine strains. Infect Immun. 64:1–9. 1996.PubMed/NCBI
|
|
7
|
Black GF, Dockrell HM, Crampin AC, et al:
Patterns and implications of naturally acquired immune responses to
environmental and tuberculous mycobacterial antigens in northern
Malawi. J Infect Dis. 184:322–329. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Black GF, Weir RE, Floyd S, et al:
BCG-induced increase in interferon-gamma response to mycobacterial
antigens and efficacy of BCG vaccination in Malawi and the UK: two
randomised controlled studies. Lancet. 359:1393–1401. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang J, Qie Y, Zhu B, et al: Evaluation of
a recombinant BCG expressing antigen Ag85B and PPE protein Rv3425
from DNA segment RD11 of Mycobacterium tuberculosis in
C57BL/6 mice. Med Microbiol Immunol. 198:5–11. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sweeney KA, Dao DN, Goldberg MF, et al: A
recombinant Mycobacterium smegmatis induces potent
bactericidal immunity against Mycobacterium tuberculosis.
Nat Med. 17:1261–1268. 2011.
|
|
11
|
Behr MA, Wilson MA, Gill WP, et al:
Comparative genomics of BCG vaccines by whole-genome DNA
microarray. Science. 284:1520–1523. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Arend SM, Andersen P, van Meijgaarden KE,
et al: Detection of active tuberculosis infection by T-cell
response to early-secreted antigenic target 6-kDa protein and
culture filtrate protein 10. J Infect Dis. 181:1850–1854. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rosenkrands I, Aagaard C, Weldingh K, et
al: Identification of Rv0222 from RD4 as a novel serodiagnostic
target for tuberculosis. Tuberculosis (Edinb). 88:335–343. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang HM, Wang JL, Lei JQ, et al: PPE
protein (Rv3425) from DNA segment RD11 of Mycobacterium
tuberculosis: a potential B-cell antigen used for serological
diagnosis to distinguish vaccinated controls from tuberculosis
patients. Clin Microbiol Infect. 13:139–145. 2007.PubMed/NCBI
|
|
15
|
Zhang SL, Zhao JW, Sun ZQ, et al:
Development and evaluation of a novel multiple-antigen ELISA for
serodiagnosis of tuberculosis. Tuberculosis (Edinb). 89:278–284.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Samten B, Wang X and Barnes PF: Immune
regulatory activities of early secreted antigenic target of 6-kD
protein of Mycobacterium tuberculosis and implications for
tuberculosis vaccine design. Tuberculosis (Edinb). 91(Suppl 1):
S114–S118. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lin PL, Dietrich J, Tan E, et al: The
multistage vaccine H56 boosts the effects of BCG to protect
cynomolgus macaques against active tuberculosis and reactivation of
latent Mycobacterium tuberculosis infection. J Clin Invest.
122:303–314. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang MM, Zhao JW, Sun ZQ, et al:
Identification of RD5-encoded Mycobacterium tuberculosis
proteins as B-cell antigens used for serodiagnosis of tuberculosis.
Clin Dev Immunol. 2012:7380432012.PubMed/NCBI
|
|
19
|
Wang J, Qie Y, Zhang H, et al: PPE protein
(Rv3425) from DNA segment RD11 of Mycobacterium
tuberculosis: a novel immunodominant antigen of
Mycobacterium tuberculosis induces humoral and cellular
immune responses in mice. Microbiol Immunol. 52:224–230.
2008.PubMed/NCBI
|
|
20
|
Metchock B, Nolte FS and Wallace RJ:
Mycobacterium. Manual of Clinical Microbiology. Murray PR, Baron
EJ, Pfaller MA, Tenover FC and Yolken RH: 7th edition. ASM Press;
Washington, DC: pp. 399–437. 1999
|
|
21
|
Zhang SL, Shen JG, Shen GH, et al: Use of
a novel multiplex probe array for rapid identification of
Mycobacterium species from clinical isolates. World J
Microbiol Biotechnol. 23:1779–1788. 2007. View Article : Google Scholar
|
|
22
|
Cooper AM: Cell-mediated immune responses
in tuberculosis. Annu Rev Immunol. 27:393–422. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
O’Garra A, Redford PS, McNab FW, Bloom CI,
Wilkinson RJ and Berry MP: The immune response in tuberculosis.
Annu Rev Immunol. 31:475–527. 2013.PubMed/NCBI
|
|
24
|
Colditz GA, Brewer TF, Berkey CS, et al:
Efficacy of BCG vaccine in the prevention of tuberculosis.
Meta-analysis of the published literature. JAMA. 271:698–702. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Keyser A, Troudt JM, Taylor JL and Izzo
AA: BCG sub-strains induce variable protection against virulent
pulmonary Mycobacterium tuberculosis infection, with the
capacity to drive Th2 immunity. Vaccine. 29:9308–9315. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Randhawa AK, Shey MS, Keyser A, et al:
Association of human TLR1 and TLR6 deficiency with altered immune
responses to BCG vaccination in South African infants. PloS Pathog.
7:e10021742011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Weir RE, Black GF, Nazareth B, et al: The
influence of previous exposure to environmental mycobacteria on the
interferon-gamma response to bacille Calmette-Guerin vaccination in
southern England and northern Malawi. Clin Exp Immunol.
146:390–399. 2006. View Article : Google Scholar
|
|
28
|
Lalor MK, Ben-Smith A, Gorak-Stolinska P,
et al: Population differences in immune responses to Bacille
Calmette-Guerin vaccination in infancy. J Infect Dis. 199:795–800.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lalor MK, Floyd S, Gorak-Stolinska P, et
al: BCG vaccination induces different cytokine profiles following
infant BCG vaccination in the UK and Malawi. J Infect Dis.
204:1075–1085. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Aagaard C, Hoang T, Dietrich J, et al: A
multistage tuberculosis vaccine that confers efficient protection
before and after exposure. Nat Med. 17:189–194. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cole ST, Brosch R, Parkhill J, et al:
Deciphering the biology of Mycobacterium tuberculosis from
the complete genome sequence. Nature. 393:537–544. 1998.
|
|
32
|
Krawczyk J, Kohl TA, Goesmann A,
Kalinowski J and Baumbach J: From Corynebacterium glutamicum
to Mycobacterium tuberculosis - towards transfers of gene
regulatory networks and integrated data analyses with MycoRegNet.
Nucleic Acids Res. 37:e972009.
|
|
33
|
Steingart KR, Dendukuri N, Henry M, et al:
Performance of purified antigens for serodiagnosis of pulmonary
tuberculosis: a meta-analysis. Clin Vaccine Immunol. 16:260–276.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mukherjee P, Dutta M, Datta P, et al: The
RD1-encoded antigen Rv3872 of Mycobacterium tuberculosis as
a potential candidate for serodiagnosis of tuberculosis. Clin
Microbiol Infect. 13:146–152. 2007.PubMed/NCBI
|
|
35
|
Mustafa AS and Al-Attiyah R:
Identification of Mycobacterium tuberculosis-specific
genomic regions encoding antigens inducing protective cellular
immune responses. Indian J Exp Biol. 47:498–504. 2009.
|
|
36
|
Wang S, Chen J, Zhang Y, et al:
Mycobacterium tuberculosis region of difference (RD) 2
antigen Rv1985c and RD11 antigen Rv3425 have the promising
potential to distinguish patients with active tuberculosis from
M. bovis BCG-vaccinated individuals. Clin Vaccine Immunol.
20:69–76. 2013. View Article : Google Scholar
|
|
37
|
Wang J, Qie Y, Liu W and Wang H:
Protective efficacy of a recombinant BCG secreting antigen
85B/Rv3425 fusion protein against Mycobacterium tuberculosis
infection in mice. Hum Vaccin Immunother. 8:2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen F, Zhai MX, Zhu YH, Qi YM, Zhai WJ
and Gao YF: In vitro and in vivo identification of a novel
cytotoxic T lymphocyte epitope from Rv3425 of Mycobacterium
tuberculosis. Microbiol Immunol. 56:548–553. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kalra M, Grover A, Mehta N, et al:
Supplementation with RD antigens enhances the protective efficacy
of BCG in tuberculous mice. Clin Immunol. 125:173–183. 2007.
View Article : Google Scholar : PubMed/NCBI
|
